Key challenges and future opportunities for LNP-based delivery
Nucleic Acid Insights 2024; 1(3), 121–125
DOI: 10.18609/nai.2024.017
Published: 19 March
Interview
Julien Couture-Senécal
Lipid nanoparticles (LNPs) face a number of hurdles, including diverse challenges and considerations around safety, efficiency, and freedom to operate. David McCall, Senior Editor, BioInsights, talks to Julien Couture-Senécal, Co-Founder and Director of Azane Therapeutics, about the key remaining questions surrounding LNPs as they continue to gain traction in the nucleic acid delivery space and beyond.